Suppr超能文献

仓鼠胰腺β细胞系HIT T15中溶解的格列本脲受体的特性分析。

Characterization of the solubilized glibenclamide receptor in a hamster pancreatic beta-cell line, HIT T15.

作者信息

Niki I, Welsh M, Berggren P O, Hubbard P, Ashcroft S J

机构信息

Nuffield Department of Clinical Biochemistry, John Radcliffe Hospital, Headington, Oxford, U.K.

出版信息

Biochem J. 1991 Aug 1;277 ( Pt 3)(Pt 3):619-24. doi: 10.1042/bj2770619.

Abstract

The glibenclamide receptor, a putative ATP-sensitive K+ channel in the hamster pancreatic beta-cell line HIT T15, was solubilized by using the zwitterionic detergent CHAPS. [3H]Glibenclamide binding was dependent on the incubation time and on the concentration of soluble membrane protein. Over 80% of [3H]glibenclamide bound could be displaced with 1 microM non-labelled glibenclamide. The curve relating specific binding to the concentration of [3H]glibenclamide (1-20 nM) showed saturation kinetics. Scatchard analysis suggested a single class of non-interacting binding sites with a Kd of 3.3 nM and a Bmax. of 90 fmol/mg of protein. [3H]Glibenclamide binding to solubilized membranes was inhibited by glibenclamide, tolbutamide and meglitinide. The relative potency of these agents on binding of [3H]glibenclamide to solubilized membranes was similar to that observed with microsomal preparations and paralleled their effects on K-ATP channel activity, measured as 86Rb efflux. These data show that the sulphonylurea receptor in the pancreatic beta-cell can be solubilized in an active form retaining specificity for sulphonylureas. ADP, which inhibits [3H]glibenclamide binding to microsomal preparations or intact HIT beta-cells, did not inhibit binding to the solubilized receptor. Incubation of intact HIT beta-cells with 125I-glibenclamide derivative followed by exposure to u.v. light resulted in covalent labelling of a peptide of 65 kDa on SDS/PAGE. The extent of labelling increased with 125I-glibenclamide derivative concentration (1-20 nM) and was inhibited in the presence of excess unlabelled glibenclamide.

摘要

在仓鼠胰腺β细胞系HIT T15中,假定的ATP敏感性钾通道——格列本脲受体,通过使用两性离子去污剂CHAPS进行增溶。[3H]格列本脲结合依赖于孵育时间和可溶性膜蛋白浓度。超过80%结合的[3H]格列本脲可被1μM未标记的格列本脲取代。将特异性结合与[3H]格列本脲浓度(1 - 20 nM)相关的曲线呈现出饱和动力学。Scatchard分析表明存在一类单一的非相互作用结合位点,解离常数(Kd)为3.3 nM,最大结合量(Bmax)为90 fmol/mg蛋白质。[3H]格列本脲与增溶膜的结合受到格列本脲、甲苯磺丁脲和米格列奈的抑制。这些药物对[3H]格列本脲与增溶膜结合的相对效力与在微粒体制剂中观察到的相似,并且与它们对以86Rb外流测量的K - ATP通道活性的影响平行。这些数据表明,胰腺β细胞中的磺酰脲受体可以以保留对磺酰脲类特异性的活性形式进行增溶。抑制[3H]格列本脲与微粒体制剂或完整HITβ细胞结合的ADP,并不抑制与增溶受体的结合。用125I - 格列本脲衍生物孵育完整的HITβ细胞,然后暴露于紫外线下,导致在SDS/PAGE上对一条65 kDa的肽进行共价标记。标记程度随125I - 格列本脲衍生物浓度(1 - 20 nM)增加,并且在过量未标记格列本脲存在时受到抑制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cad3/1151286/9b6ed2ac630e/biochemj00154-0052-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验